T0	Limitation 26838 26846	Firstly,
T1	Limitation 27883 27885	In
T2	Limitation 28207 28215	Finally,
T3	Limitation 28607 28615	However,
T4	Limitation 28827 28830	For
T6	Limitation 30285 30288	Nor
T7	UnderpoweredStudy 27012 27116	the overall cure rate achieved in this trial was much lower at 14% with a 0.65% difference in cure rates
T8	Limitation 27119 27127	Secondly
T9	FollowUpDuration 27156 27297	a six month follow-up is a more realistic time point at which to assess the success of treatments of cutaneous warts than shorter time frames
T10	ActivePlacebo 28087 28117	the lack of a no treatment arm
T11	Intervention 28328 28441	we collected patient self reported data on adherence to treatment only at one and three weeks after randomisation
T12	Intervention 28775 28817	a lower adherence for the treatment period
T13	NonstandardTreatmentCharacteristics 30285 30392	Nor did we evaluate the effectiveness of salicylic acid treatment if delivered by a healthcare professional
T14	Limitation 27003 27010	However
